Diagnostics
Total Trials
3
As Lead Sponsor
0
As Collaborator
Total Enrollment
142
NCT02474888
Pharmacokinetic Study of Rituximab Induction Regimen in ANCA-associated Vasculitis
Phase: N/A
Role: Collaborator
Start: Sep 15, 2015
Completion: Jun 12, 2020
NCT02768532
Value of Pharmacokinetic Assays in the Prediction of Induction and Maintenance Therapeutic Response in Crohn's Disease
Phase: Phase 4
Start: Jul 1, 2016
Completion: Jan 23, 2023
NCT03724929
Value of Pharmacokinetic Assays in the Prediction of Therapeutic Response in Ulcerative Colitis
Start: Mar 4, 2019
Completion: Jun 28, 2022
Loading map...